Home/Filings/4/0001209191-20-004808
4//SEC Filing

WIGGINS MARK C 4

Accession 0001209191-20-004808

CIK 0001394319other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:10 PM ET

Size

5.2 KB

Accession

0001209191-20-004808

Insider Transaction Report

Form 4
Period: 2020-01-23
WIGGINS MARK C
Chief Business Officer
Transactions
  • Purchase

    Common Stock

    2020-01-23$4.02/sh+5,000$20,1035,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.995 to $4.0284, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above

Issuer

Tracon Pharmaceuticals, Inc.

CIK 0001394319

Entity typeother

Related Parties

1
  • filerCIK 0001236540

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:10 PM ET
Size
5.2 KB